실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,268+프로그램
35+FDA 승인
4,079+모집 중
ADC 1068·Antibody 5456·CGT 2744차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
0오늘 방문
568누적 방문
8122갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
다음 갱신 D-13 · 마지막 7월 13일
ADCBiologicOnconic Therapeutics Inc.releasePhase 2

PARP inhibitor (PARP inhibitor)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 27.66%임상시험 60상태 RECRUITING
CGTBiologicMerck Sharp & Dohme LLCPhase 2

Interferon-alpha (Interferon-alpha)

Lymphoproliferative Disorder; HHV-8 · Lymphoproliferative Disorder

#LymphoproliferativeDisorder#CGT#Phase2#인기#세포유전치료+5
임상시험 59상태 RECRUITING
AntibodyUCB PharmaApproved

Certolizumab (Certolizumab)

Psoriasis; Atopic Dermatitis · Chronic Nonbacterial Osteomyelitis

#ChronicNonbacterialOsteomyelitis#Antibody#Approved#인기#항체+5
효능 ORR 5%임상시험 59상태 RECRUITING
AntibodyBristol Myers SquibbPhase 2

nivolumab (Opdivo, Ipilimumab and nivolumab)

Mesothelioma; Pancreatic Cancer · Uveal Melanoma, Metastatic

#UvealMelanomaMetastatic#Antibody#Phase2#인기#항체+5
효능 ORR 77.8%임상시험 59상태 RECRUITING
ADCBiologicFondazione per la Medicina Pers…releasePhase 2

Alpelisib (Alpelisib)

Breast Cancer; Gastrointestinal Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 43.3%임상시험 59상태 DISCONTINUED
ADCBiologicSWOG Cancer Research NetworkDM1) and/or trastuzumab der…Phase 3

HER2-targeted Therapy (HER2-targeted Therapy)

Anatomic Stage IV Breast Cancer AJCC v8; Metastatic HER2-Positive Breast Carcinoma · HER2

#HER2#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 18.75%임상시험 59상태 RECRUITING
ADCBiologicMing-Yuan ChenPhase 3

Adjuvant Cisplatin (Adjuvant Cisplatin)

Locally Advanced Head and Neck Squamous Cell Carcinoma · Locally Advanced Head and Neck Squamous

#LocallyAdvancedHeadandNeckSquamo#ADC#Phase3#인기#항체약물접합체+2
효능 ORR 40%임상시험 59상태 RECRUITING
CGTBiologicBinhui Biopharmaceutical Co., L…Phase 1

IDOV-SAFETM (Oncolytic Virus injection, Oncolytic Virus injection(IDOV-SAFETM))

Neoplasms · Neoplasms

#Neoplasms#CGT#Phase1#인기#세포유전치료+4
효능 ORR 28%임상시험 59상태 RECRUITING
CGTBiologicImmunityBio, Inc.sPhase 2

Activated NK Cells (M-CENK, M-CENK (Activated NK Cells))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#인기#세포유전치료+4
임상시험 59상태 DISCONTINUED
CGTBiologicSPP Pharmaclon Ltd.Phase 2

Recombinant Interferon Alfa (Recombinant Interferon Alfa)

Colorectal Cancer; Kidney Cancer · Bladder Cancer

#BladderCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 32.4%임상시험 59상태 ACTIVE
ADCBiologicHoffmann-La RochePhase 2

Vismodegib (Vismodegib)

Cancer of Unknown Primary Site · FRα

#FR#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 88%임상시험 59상태 DISCONTINUED
ADCBiologicKaryopharm Therapeutics IncPhase 2

Clarithromycin (Clarithromycin)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#인기#항체약물접합체+2
효능 ORR 6%임상시험 59상태 RECRUITING
CGTBiologicInge Marie SvanePhase 1

Proleukin (Proleukin)

Melanoma Stage III; Melanoma Stage IV · Melanoma Stage III

#MelanomaStageIII#CGT#Phase1#인기#세포유전치료+5
효능 ORR 33.3%임상시험 59상태 RECRUITING
ADCBiologicRocheDM1 via butelase-1 with ABD…Phase 3

T-DM1 (Trastuzumab emtansine, Trastuzumab emtansine (T-DM1))

Advanced Breast Cancer; Objective Response Rate · HER2

#HER2#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 69.7%임상시험 59상태 RECRUITING
ADCBiologicSWOG Cancer Research NetworksPhase 3

Afatinib Dimaleate (Afatinib Dimaleate)

Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer · FRα

#FR#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 96%임상시험 59상태 RECRUITING
ADCBiologicMonika Joshi, MDviaPhase 3

Eribulin mesylate (Eribulin mesylate)

Metastatic Urothelial Cell Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 71.2%임상시험 59상태 RECRUITING
ADCBiologicGenentech, Inc.Preclinical

Anti-angiogenic drug (Anti-angiogenic drug)

Gastric Cancer; Second-line Treatment · Gastric Cancer

#GastricCancer#ADC#Preclinical#인기#항체약물접합체+3
효능 ORR 96%임상시험 59상태 RECRUITING
AntibodyRegeneronDemonstratePhase 2

Cemiplimab + Fianlimab [Fixed Dose Combination (FDC, Cemiplimab + Fianlimab [Fixed Dose Combination, Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)])

Ovarian Cancer; Fallopian Tube Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#인기#항체+5
효능 ORR 100%임상시험 59상태 RECRUITING
CGTBiologicCelgenevedotin (BV) maintenance th…Phase 2

ASCT (ASCT)

Multiple Myeloma; Newly Diagnosed · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#인기#세포유전치료+5
효능 ORR 11%임상시험 59상태 RECRUITING
CGTBiologicAbClonvedotin-containing regimens…Phase 2

Anti-CD19 Chimeric Antigen Receptor T cell (AT101, AT101(Anti-CD19 Chimeric Antigen Receptor T cell))

B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#인기#세포유전치료+5
효능 ORR 38%임상시험 59상태 RECRUITING
ADCBiologicGenzyme, a Sanofi Companyvedotin-based regimens in C…Phase 2

Reduced Intensity Conditioning (Reduced Intensity Conditioning)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 2%임상시험 59상태 ACTIVE
ADCBiologicNYU Langone HealthPhase 2

Leflunomide (Leflunomide)

Rheumatic Disease · Takayasu Arteritis

#TakayasuArteritis#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 6.35%임상시험 59상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCsPhase 2

Hyaluronidase (Hyaluronidase)

Diffuse Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 64.3%임상시험 59상태 DISCONTINUED
CGTBiologicMedigen Vaccine Biologics Corp.Phase 1

Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell, Recombinant Oncolytic HSV-2 Therapeutic Injecta, Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF))

Melanoma Stage IV · Melanoma Stage IV

#MelanomaStageIV#CGT#Phase1#인기#세포유전치료+4
임상시험 58상태 ACTIVE
AntibodyGenentech, Inc.Phase 2

Ocrelizumab (Ocrelizumab)

Rheumatoid Arthritis · Multiple Sclerosis

#MultipleSclerosis#Antibody#Phase2#인기#항체+5
임상시험 58상태 DISCONTINUED

13 / 167 페이지

← 이전다음 →
전체 9,268개 프로그램 보기